Literature DB >> 15332274

Major histocompatibility complex class-I presentation impaired in transgenic mice expressing hepatitis C virus structural proteins during dendritic cell maturation.

Yoichi Hiasa1, Hidemi Takahashi, Masumi Shimizu, Hideko Nuriya, Kyoko Tsukiyama-Kohara, Takeshi Tanaka, Norio Horiike, Morikazu Onji, Michinori Kohara.   

Abstract

Hepatitis C virus (HCV) infection is often persistent, but its mechanism and pathogenesis remain unclear. One mechanism through which HCV escapes systemic immunosurveillance might be via impaired dendritic cells (DCs), which are the most potent type of antigen-presenting cells. We examined whether HCV causes immunosuppression in DCs during maturation. We isolated immature DCs from the bone marrow of two founder lineages of transgenic mice harboring HCV cDNA expressing HCV structural proteins (nucleotides 294-3435), and studied how DC function is modified by HCV expression. Our data showed that the capacity of DCs expressing HCV structural proteins to stimulate T-cells was significantly impaired. Moreover, the surface expression of major histocompatibility complex (MHC) class-I molecules was significantly impaired on infected DC, especially with respect to H-2D. The transportation of H-2D to the cell surface during DC maturation was inhibited by HCV expression. However, the total amount of H-2D molecules produced by DC expressing HCV was not impaired. These results indicated that the immune response of DC infected with HCV is diminished and might be associated with the mechanism of persistent HCV infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15332274     DOI: 10.1002/jmv.20164

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  4 in total

1.  Hepatitis C and innate immunity: recent advances.

Authors:  Gyongyi Szabo; Angela Dolganiuc
Journal:  Clin Liver Dis       Date:  2008-08       Impact factor: 6.126

2.  Immune regulation and evasion of Mammalian host cell immunity during viral infection.

Authors:  B M Pratheek; Soham Saha; Prasanta K Maiti; Soma Chattopadhyay; Subhasis Chattopadhyay
Journal:  Indian J Virol       Date:  2013-03-15

3.  High serum palmitic acid is associated with low antiviral effects of interferon-based therapy for hepatitis C virus.

Authors:  Teruki Miyake; Yoichi Hiasa; Masashi Hirooka; Yoshio Tokumoto; Takao Watanabe; Shinya Furukawa; Teruhisa Ueda; Shin Yamamoto; Teru Kumagi; Hiroaki Miyaoka; Masanori Abe; Bunzo Matsuura; Morikazu Onji
Journal:  Lipids       Date:  2012-09-16       Impact factor: 1.880

Review 4.  Dendritic cells in hepatitis C infection: can they (help) win the battle?

Authors:  Angela Dolganiuc; Gyongyi Szabo
Journal:  J Gastroenterol       Date:  2011-02-17       Impact factor: 6.772

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.